Enginzyme AB, a deep-tech company delivering optimized biomanufacturing solutions through cell-free enzyme engineering technology, announced that it had appointed Aymeric de Gantès as CEO. Founder...
Sanofi announced the successful completion of its acquisition of DR-0201, a targeted bispecific myeloid cell engager, from Dren Bio, a privately held, clinical-stage biopharmaceutical...
KROMATID, a leader in structural genomics innovation, is proud to announce the release of an expanded capability for its Advanced Cytogenetics Platform. KROMASURE™ PinPoint provides a...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
At ISPOR Montreal 2025 Conference, CapeStart, announced a major new release of MadeAi™-its award-winning generative AI-based platform that expedites the synthesis of content and...
